Avanir Pharmaceuticals



Avanir Pharmaceuticals is dedicated to the research and development of cutting-edge treatments and therapies for disorders of the central nervous system (CNS).

Wa'el Hashad
President and Chief Executive Officer
Wa'el Hashad
Aneta Ferguson
Vice President, General Counsel
Dan Dalton
Senior Vice President & Chief Compliance Officer
Hisanori Maei
Vice President, Business Planning & Alliance Management
Kelly Parker
Vice President, Chief People Officer
Lisa Locklear
Senior Vice President and Chief Financial Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.